Long-term Efficacy and Safety of Ultra Rapid Lispro in Japanese Patients With Type 1 Diabetes: Subpopulation Analysis of the 52-Week PRONTO-T1D Study

INTRODUCTION: The PRONTO-T1D study evaluated the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes mellitus. After 26 weeks of treatment, mealtime and postmeal URLi provided effective and comparable glycemic control in a prespecified subpopulation analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Junnosuke, Nishiyama, Hiroshi, Imori, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385092/
https://www.ncbi.nlm.nih.gov/pubmed/34347267
http://dx.doi.org/10.1007/s13300-021-01124-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385092/
https://www.ncbi.nlm.nih.gov/pubmed/34347267
http://dx.doi.org/10.1007/s13300-021-01124-9

Ejemplares similares